TNF-α/IL-17 synergy inhibits IL-13 bioactivity via IL-13Rα2 induction

Journal of Allergy and Clinical Immunology

Volumn 134, Issue 4, 2014, Pages 975-978.e5

  Badalyan, Vahe ^a,b   Thompson, Robert ^a   Addo, Kezia ^a   Borthwick, Lee A ^c   Fisher, Andrew J ^c   Ort, Tatiana ^d   Myers, Timothy G ^a   Wynn, Thomas A ^a   Ramalingam, Thirumalai R ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d Janssen RandD Companies of Johnson and Johnson   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 13 RECEPTOR ALPHA2; INTERLEUKIN 17; TRANSCRIPTOME; TUMOR NECROSIS FACTOR ALPHA; INTERLEUKIN 13; INTERLEUKIN 4;

ANIMAL CELL; ASTHMA; CYTOKINE PRODUCTION; DISEASE EXACERBATION; HELMINTHIASIS; HUMAN; HUMAN CELL; IMMUNOMODULATION; INFLAMMATION; INTRACELLULAR SIGNALING; LETTER; LUNG FIBROBLAST; MOUSE; MUCUS SECRETION; NONHUMAN; ANIMAL; CELL CULTURE; FIBROBLAST; GENETICS; IMMUNOLOGY; IMMUNOTHERAPY; LUNG; METABOLISM; MOLECULARLY TARGETED THERAPY; PATHOLOGY; UPREGULATION;

ANIMALS; ASTHMA; CELLS, CULTURED; FIBROBLASTS; HUMANS; IMMUNOTHERAPY; INTERLEUKIN-13; INTERLEUKIN-13 RECEPTOR ALPHA2 SUBUNIT; INTERLEUKIN-17; INTERLEUKIN-4; LUNG; MICE; MOLECULAR TARGETED THERAPY; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84908121772     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2014.05.019     Document Type: Article

References (13)

1. T.A. Wynn IL-13 effector functions Annu Rev Immunol 21 2003 425 456
2. T.R. Ramalingam, J.T. Pesce, F. Sheikh, A.W. Cheever, M.M. Mentink-Kane, and M.S. Wilson Unique functions of the type II interleukin 4 receptor identified in mice lacking the interleukin 13 receptor alpha1 chain Nat Immunol 9 2008 25 33
3. Y. Tabata, and G.K. Khurana Hershey IL-13 receptor isoforms: breaking through the complexity Curr Allergy Asthma Rep 7 2007 338 345
4. M. O'Toole, H. Legault, R. Ramsey, T.A. Wynn, and M.T. Kasaian A novel and sensitive ELISA reveals that the soluble form of IL-13R-alpha2 is not expressed in plasma of healthy or asthmatic subjects Clin Exp Allergy 38 2008 594 601
5. S. Fichtner-Feigl, W. Strober, K. Kawakami, R.K. Puri, and A. Kitani IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis Nat Med 12 2006 99 106
6. M. Yoshikawa, T. Nakajima, T. Tsukidate, K. Matsumoto, M. Iida, and N. Otori TNF-alpha and IL-4 regulate expression of IL-13 receptor alpha2 on human fibroblasts Biochem Biophys Res Commun 312 2003 1248 1255
7. G. Campbell-Harding, H. Sawkins, N. Bedke, S.T. Holgate, D.E. Davies, and A.L. Andrews The innate antiviral response upregulates IL-13 receptor alpha2 in bronchial fibroblasts J Allergy Clin Immunol 131 2013 849 855
8. J. Corren, R.F. Lemanske, N.A. Hanania, P.E. Korenblat, M.V. Parsey, and J.R. Arron Lebrikizumab treatment in adults with asthma N Engl J Med 365 2011 1088 1098
9. S.F. Seys, M. Grabowski, W. Adriaensen, A. Decraene, E. Dilissen, and J.A. Vanoirbeek Sputum cytokine mapping reveals an 'IL-5, IL-17A, IL-25-high' pattern associated with poorly controlled asthma Clin Exp Allergy 43 2013 1009 1017
10. D.C. Newcomb, M.G. Boswell, W. Zhou, M.M. Huckabee, K. Goleniewska, and C.M. Sevin Human TH17 cells express a functional IL-13 receptor and IL-13 attenuates IL-17A production J Allergy Clin Immunol 127 2011 1006 1013 e1-4
11. M.I. Suwara, N.J. Green, L.A. Borthwick, J. Mann, K.D. Mayer-Barber, and L. Barron IL-1alpha released from damaged epithelial cells is sufficient and essential to trigger inflammatory responses in human lung fibroblasts Mucosal Immunol 7 2014 684 693
12. M.E. Banwell, N.S. Tolley, T.J. Williams, and T.J. Mitchell Regulation of human eotaxin-3/CCL26 expression: modulation by cytokines and glucocorticoids Cytokine 17 2002 317 323
13. J. Hoeck, and M. Woisetschlager Activation of eotaxin-3/CCLl26 gene expression in human dermal fibroblasts is mediated by STAT6 J Immunol 167 2001 3216 3222